| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer
|
Boukovala, Myrto
|
|
|
127 |
C |
p. 67-75
|
artikel
|
| 2 |
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
|
Pearson, Andrew D.J.
|
|
|
127 |
C |
p. 52-66
|
artikel
|
| 3 |
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
|
Van Cutsem, E.
|
|
|
127 |
C |
p. 150-157
|
artikel
|
| 4 |
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
|
Felip, Enriqueta
|
|
|
127 |
C |
p. 160-172
|
artikel
|
| 5 |
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review
|
Jansen, Erik E.L.
|
|
|
127 |
C |
p. 207-223
|
artikel
|
| 6 |
Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial
|
Fastner, Gerd
|
|
|
127 |
C |
p. 12-20
|
artikel
|
| 7 |
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review
|
Zielonke, Nadine
|
|
|
127 |
C |
p. 191-206
|
artikel
|
| 8 |
Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16)
|
Park, Inkeun
|
|
|
127 |
C |
p. 183-190
|
artikel
|
| 9 |
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review
|
Gini, Andrea
|
|
|
127 |
C |
p. 224-235
|
artikel
|
| 10 |
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review
|
Auer, Rebecca C.
|
|
|
127 |
C |
p. 76-95
|
artikel
|
| 11 |
Induction of apoptosis increases sensitivity to detect cancer mutations in plasma
|
Marques, Joana F.
|
|
|
127 |
C |
p. 130-138
|
artikel
|
| 12 |
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)
|
Casanova, Michela
|
|
|
127 |
C |
p. 123-129
|
artikel
|
| 13 |
Intratumoural immunotherapies in oncology
|
Xu, Wen
|
|
|
127 |
C |
p. 1-11
|
artikel
|
| 14 |
Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer?
|
Sridhar, Srikala S.
|
|
|
127 |
C |
p. 158-159
|
artikel
|
| 15 |
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
|
Cafferty, Fay H.
|
|
|
127 |
C |
p. 139-149
|
artikel
|
| 16 |
Melanoma recognition by a deep learning convolutional neural network—Performance in different melanoma subtypes and localisations
|
Winkler, Julia K.
|
|
|
127 |
C |
p. 21-29
|
artikel
|
| 17 |
Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer
|
Bhardwaj, Megha
|
|
|
127 |
C |
p. 30-40
|
artikel
|
| 18 |
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
|
Lamping, Mario
|
|
|
127 |
C |
p. 41-51
|
artikel
|
| 19 |
Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used
|
Ogata, Dai
|
|
|
127 |
C |
p. 108-117
|
artikel
|
| 20 |
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
|
|
|
|
127 |
C |
p. 96-107
|
artikel
|
| 21 |
The role of site-specific therapy for cancers of unknown of primary: A meta-analysis
|
Rassy, Elie
|
|
|
127 |
C |
p. 118-122
|
artikel
|
| 22 |
Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumours
|
Criscitiello, Carmen
|
|
|
127 |
C |
p. 236-239
|
artikel
|
| 23 |
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy
|
de Boo, Leonora
|
|
|
127 |
C |
p. 240-250
|
artikel
|
| 24 |
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
|
Holmsten, Karin
|
|
|
127 |
C |
p. 173-182
|
artikel
|
Tijdschrift beschrijving